Vascular Closure Devices - Global Strategic Business Report

The global market for Vascular Closure Devices was valued at US$938.2 Million in 2024 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Vascular Closure Devices market.

Global Vascular Closure Devices Market - Key Trends & Drivers Summarized

What Are Vascular Closure Devices and How Do They Transform Patient Care?

Vascular closure devices (VCDs) are medical instruments used to seal puncture sites in arteries following cardiovascular procedures such as angiography or angioplasty. These devices offer a significant advancement over traditional manual compression methods, enhancing patient comfort and reducing the time required for hemostasis (the cessation of bleeding). VCDs fall into several categories, including collagen plugs, suture-based systems, and clip-based systems, each designed to provide rapid and reliable closure of arterial access sites. Their use minimizes the risk of complications such as bleeding and vascular injury, facilitating faster patient recovery and shorter hospital stays.

How Is Technological Innovation Impacting the VCD Market?

Technological advancements are at the forefront of driving innovations in the design and functionality of vascular closure devices. Recent developments include bioabsorbable materials that naturally dissolve in the body, reducing the risk of infection and other long-term complications associated with foreign objects left in the body. Additionally, advancements in device deployment mechanisms have led to more user-friendly designs that ensure more consistent and successful closures. Imaging technologies have also improved, aiding physicians in the accurate placement of VCDs, thereby increasing the efficacy and safety of procedures.

What Are the Clinical and Economic Benefits of Vascular Closure Devices?

From a clinical perspective, VCDs significantly enhance patient outcomes by reducing the incidence of complications associated with vascular access points. They enable immediate ambulation post-procedure, which is crucial for elderly patients or those with mobility issues. Economically, the use of VCDs can lead to cost savings for healthcare facilities by reducing the duration of post-procedure care and minimizing the need for additional staff during the recovery period. These devices also play a critical role in optimizing patient throughput in hospitals, allowing for the treatment of more patients and better utilization of resources.

What Drives the Growth in the Vascular Closure Devices Market?

The growth in the vascular closure devices market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, which increases the demand for interventional procedures requiring VCDs. Technological advancements that enhance the safety and efficacy of these devices also contribute to market expansion. Additionally, the growing preference for minimally invasive surgeries among both patients and healthcare providers boosts the adoption of VCDs. The market is further supported by the increasing number of elderly populations, who are more prone to vascular diseases and benefit significantly from the quick recovery times associated with VCDs. Moreover, healthcare providers' emphasis on reducing procedure times and improving operational efficiencies continues to drive the adoption of advanced vascular closure technologies.

Report Scope

The report analyzes the Vascular Closure Devices market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Type (Passive Approximators, Active Approximators, External Hemostatic Devices); Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery); Access (Femoral, Radial).

Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Passive Approximators segment, which is expected to reach US$996.3 Million by 2030 with a CAGR of a 8.2%. The Active Approximators segment is also set to grow at 6.7% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $387.1 Million in 2024, and China, forecasted to grow at an impressive 8.8% CAGR to reach $154.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Vascular Closure Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Closure Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Vascular Closure Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Cardinal Health, Inc., Terumo Corporation, W. L. Gore & Associates, Inc., Teleflex, Inc., Cordis, a Cardinal Health company and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 36 companies featured in this Vascular Closure Devices market report include:

• Cardinal Health, Inc.
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Teleflex, Inc.
• Cordis, a Cardinal Health company
• Merit Medical Systems, Inc.
• Elixir Medical Corporation
• Tricol Biomedical, Inc.
• Marine Polymer Technologies, Inc.
• Axio Biosolutions Private Limited
• Endocor GmbH

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry